Accuracy of Risk Estimation for Surgeons Versus Risk Calculators in Emergency General Surgery.

Huckaby LV, Dadashzadeh ER, Li S, Campwala I, Gabriel L, Sperry J, Handzel RM, Forsythe R, Brown J

Anatomic safe zones for arthroscopic snapping scapula surgery: quantitative anatomy of the superomedial scapula and associated neurovascular structures and the effects of arm positioning on safety.

Dey Hazra RO, Elrick BP, Ganokroj P, Nolte PC, Fossum BW, Brown JR, Hanson JA, Douglass BW, Dey Hazra ME, Provencher MT, Millett PJ

The Importance of Defining Actionability as Related to Disclosure of Secondary Findings Identified in Research.

Brown J, Howard D

Comment on "Activation of the Omega-3 Fatty Acid Receptor GPR120 Protects against Focal Cerebral Ischemic Injury by Preventing Inflammation and Apoptosis in Mice".

Brown JL, Murphy KA, O'Connell TD, Lesné SE

EXABS-179-CLL DEBATE: Sequencing Small Molecules Is the Way to Go.

Brown JR

CLL-120 Pirtobrutinib, A Highly Selective, Non-Covalent (Reversible) BTK Inhibitor in Previously Treated CLL/SLL: Updated Results from the Phase 1/2 BRUIN Study.

Coombs CC, Pagel JM, Shah NN, Lamanna N, Munir T, Lech-Maranda E, Eyre TA, Woyach JA, Wierda WG, Cheah CY, Cohen JB, Roeker LE, Patel MR, Fakhri B, Barve MA, Tam CS, Lewis D, Gerson JN, Alencar A, Ujjani C, Flinn I, Sundaram S, Ma S, Jagadeesh D, Rhodes J, Taylor J, Abdel-Wahab O, Ghia P, Schuster SJ, Wang D, Nair B, Zhu E, Tsai DE, Davids MS, Brown JR, Jurczak W, Mato AR

Evaluation of an Outpatient and Telehealth Initiative to Reduce Tube Dependency in Infants with Complex Congenital Heart Disease.

Horsley M, Hill GD, Kaskie S, Schnautz M, Brown J, Marcuccio E

The PRO model accounts for the anterior cingulate cortex role in risky decision-making and monitoring.

Woo JH, Azab H, Jahn A, Hayden B, Brown JW

CLL-137 SEQUOIA: Results of a Phase 3 Randomized Study of Zanubrutinib Versus Bendamustine + Rituximab (BR) in Patients With Treatment-Naïve (TN) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/ SLL).

Kahl BS, Giannopoulos K, Jurczak W, Šimkovič M, Shadman M, Österborg A, Laurenti L, Walker P, Opat S, Chan H, Ciepluch H, Greil R, Tani M, Trnéný M, Brander DM, Flinn IW, Grosicki S, Verner E, Brown JR, Ghia P, Li J, Tian T, Zhou L, Marimpietri C, Paik JC, Cohen A, Robak T, Hillmen P, Tam CS

CLL-115 First Interim Analysis of ALPINE Study: Results of a Phase 3 Randomized Study of Zanubrutinib vs Ibrutinib in Patients With Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL).

Brown JR, Hillmen P, Eichhorst B, Lamanna N, O'Brien S, Tam CS, Qiu L, Kazmierczak M, Zhou K, Šimkovič M, Mayer J, Gillespie-Twardy A, Shadman M, Ferrajoli A, Ganly PS, Weinkove R, Salmi T, Wu K, Novotny W, Jurczak W